Inhibrx Biosciences, Inc. (INBX)
101.32
-9.25
(-8.37%)
USD |
NASDAQ |
May 22, 16:00
101.37
+0.05
(+0.05%)
After-Hours: 20:00
Inhibrx Biosciences Market Cap : 1.486B for May 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 302.33B |
| Biogen, Inc. | 28.61B |
| Catalyst Pharmaceuticals, Inc. | 3.826B |
| Inovio Pharmaceuticals, Inc. | 111.07M |
| Capricor Therapeutics, Inc. | 1.672B |
Market Cap Related Metrics
| PS Ratio | 1209.29 |
| Price | 101.32 |
| Earnings Yield | -8.28% |